Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Dermatitis Herpetiformis Differential Diagnoses

  • Author: Jami L Miller, MD; Chief Editor: Dirk M Elston, MD  more...
 
Updated: Mar 31, 2016
 
 
 
Contributor Information and Disclosures
Author

Jami L Miller, MD Assistant Professor, Division of Dermatology, Department of Internal Medicine, Vanderbilt University Medical School; Director of Phototherapy Unit, Vanderbilt University Medical Center; Consulting Attending Physician, Nashville Veterans Affairs Medical Center

Jami L Miller, MD is a member of the following medical societies: American Academy of Dermatology, American College of Physicians, American Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Shehnaz Aysha K Zaman, MD Resident Physician, Department of Dermatology, Vanderbilt Medical Center

Disclosure: Nothing to disclose.

Specialty Editor Board

Michael J Wells, MD, FAAD Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine

Michael J Wells, MD, FAAD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Texas Medical Association

Disclosure: Nothing to disclose.

Julia R Nunley, MD Professor, Program Director, Dermatology Residency, Department of Dermatology, Virginia Commonwealth University Medical Center

Julia R Nunley, MD is a member of the following medical societies: American Academy of Dermatology, American College of Physicians, American Society of Nephrology, International Society of Nephrology, Medical Dermatology Society, Medical Society of Virginia, National Kidney Foundation, Phi Beta Kappa, Women's Dermatologic Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: American Board of Dermatology<br/>Co-Editor for the text Dermatological Manifestations of Kidney Disease .

Chief Editor

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Additional Contributors

Russell Hall, MD J Lamar Callaway Professor And Chair, Department of Dermatology, Duke University Medical Center, Duke University School of Medicine

Russell Hall, MD is a member of the following medical societies: American Academy of Dermatology, American Federation for Medical Research, American Society for Clinical Investigation, Society for Investigative Dermatology

Disclosure: Received consulting fee from Novan for consulting; Received consulting fee from Stieffel, a GSK company for consulting; Received salary from Society for Investigative Dermatology for board membership.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous authors, Kristina Collins, MD, and Hunter Sams, MD, to the development and writing of this article.

References
  1. Duhring L. Dermatitis herpetiformis. JAMA. 1884. 3:225.

  2. Arbache ST, Nogueira TG, Delgado L, Miyamoto D, Aoki V. Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience. An Bras Dermatol. 2014 Nov-Dec. 89 (6):885-9. [Medline].

  3. Plotnikova N, Miller JL. Dermatitis herpetiformis. Skin Therapy Lett. 2013 Mar. 18(3):1-3. [Medline].

  4. Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med. 2002 Mar 18. 195(6):747-57. [Medline].

  5. Hull CM, Liddle M, Hansen N, et al. Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis. Br J Dermatol. 2008 Jul. 159(1):120-4. [Medline].

  6. Marietta EV, Camilleri MJ, Castro LA, Krause PK, Pittelkow MR, Murray JA. Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue. J Invest Dermatol. 2008 Feb. 128(2):332-5. [Medline].

  7. Cannistraci C, Lesnoni La Parola I, et al. Co-localization of IgA and TG3 on healthy skin of coeliac patients. J Eur Acad Dermatol Venereol. 2007 Apr. 21(4):509-14. [Medline].

  8. Samolitis NJ, Hull CM, Leiferman KM, Zone JJ. Dermatitis herpetiformis and partial IgA deficiency. J Am Acad Dermatol. 2006 May. 54(5 Suppl):S206-9. [Medline].

  9. Hall RP 3rd, Benbenisty KM, Mickle C, Streiien RD. Serum IL-8 in patients with dermatitis herpetiformis is produced in response to dietary gluten. J Invest Dermatol. 2007 Sept. 127(9):2158-67. [Medline].

  10. Hall RP 3rd, Takeuchi F, Benbenisty KM, Streilein RD. Cutaneous endothelial cell activation in normal skin of patients with dermatitis herpetiformis associated with increased serum levels of IL-8, sE-Selectin, and TNF-alpha. J Invest Dermatol. 2006 Jun. 126(6):1331-7. [Medline].

  11. Dahl MV, Falk RJ, Carpenter R, Michael AF. Membrane attack complex of complement in dermatitis herpetiformis. Arch Dermatol. 1985 Jan. 121(1):70-2. [Medline].

  12. Zebrowska A, Wagrowska-Danilewicz M, et al. Expression of selected ADAMs in bullous pemphigoid and dermatitis herpetiformis. Journal of Dermatological Science. 2009. 56:58-73.

  13. Grimwood RE, Guevara A. Leuprolide acetate-induced dermatitis herpetiformis. Cutis. 2005 Jan. 75(1):49-52. [Medline].

  14. Caproni M, Torchia D, Antiga E, et al. The role of apoptosis in the pathogenesis of dermatitis herpetiformis. Int J Immunopathol Pharmacol. 2005 Oct-Dec. 18(4):691-9. [Medline].

  15. Smecuol E, Sugai E, Niveloni S, et al. Permeability, zonulin production, and enteropathy in dermatitis herpetiformis. Clin Gastroenterol Hepatol. 2005 Apr. 3(4):335-41. [Medline].

  16. Bardella MT, Fredella C, Saladino V, et al. Gluten intolerance: gender- and age-related differences in symptoms. Scand J Gastroenterol. 2005 Jan. 40(1):15-9. [Medline].

  17. Templet JT, Welsh JP, Cusack CA. Childhood dermatitis herpetiformis: a case report and review of the literature. Cutis. 2007 Dec. 80(6):473-6. [Medline].

  18. Lahteenoja H, Irjala K, Viander M, Vainio E, Toivanen A, Syrjanen S. Oral mucosa is frequently affected in patients with dermatitis herpetiformis. Arch Dermatol. 1998 Jun. 134(6):756-8. [Medline].

  19. Hardman CM, Garioch JJ, Leonard JN, et al. Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med. 1997 Dec 25. 337(26):1884-7. [Medline].

  20. Garsed K, Scott BB. Can oats be taken in a gluten-free diet? A systematic review. Scand J Gastroenterol. 2007 Feb. 42(2):171-8. [Medline].

  21. Al-Niaimi F,Cox NH,Lewis-Jones S. Dermatitis herpetiformis exacerbated by cornstarch. JAAD. 2010. 62:510-511.

  22. Accetta P, Kumar V, Beutner EH, Chorzelski TP, Helm F. Anti-endomysial antibodies. A serologic marker of dermatitis herpetiformis. Arch Dermatol. 1986 Apr. 122(4):459-62. [Medline].

  23. Schulze F, van Beek N, Terheyden P, Zillikens D, Schmidt E. Concomitant Bullous Pemphigoid and Dermatitis Herpetiformis. Dermatology. 2013 Jun 14. [Medline].

  24. Gaspari AA, Huang CM, Davey RJ, Bondy C, Lawley TJ, Katz SI. Prevalence of thyroid abnormalities in patients with dermatitis herpetiformis and in control subjects with HLA-B8/-DR3. Am J Med. 1990 Feb. 88(2):145-50. [Medline].

  25. Helsing P, Froen H. Dermatitis herpetiformis presenting as ataxia in a child. Acta Derm Venereol. 2007. 87(2):163-5. [Medline].

  26. Sigurgeirsson B, Agnarsson BA, Lindelöf B. Risk of lymphoma in patients with dermatitis herpetiformis. BMJ. 1994 Jan 1. 308(6920):13-5. [Medline]. [Full Text].

  27. Hassan S, Dalle S, Descloux E, Balme B, Thomas L. [Dermatitis herpetiformis associated with progesterone contraception]. Ann Dermatol Venereol. 2007 Apr. 134(4 Pt 1):385-6. [Medline].

  28. George DE, Browning JC, Hsu S. Medical pearl: dermatitis herpetiformis--potential for confusion with eczema. J Am Acad Dermatol. 2006 Feb. 54(2):327-8. [Medline].

  29. Alonso-Llamazares J, Gibson LE, Rogers RS 3rd. Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience. Int J Dermatol. 2007 Sep. 46(9):910-9. [Medline].

  30. Antiga E, Verdelli A, Calabrò A, Fabbri P, Caproni M. Clinical and immunopathological features of 159 patients with dermatitis herpetiformis: an Italian experience. G Ital Dermatol Venereol. 2013 Apr. 148(2):163-9. [Medline].

  31. Desai AM, Krishnan RS, Hsu S. Medical pearl: Using tissue transglutaminase antibodies to diagnose dermatitis herpetiformis. J Am Acad Dermatol. 2005 Nov. 53(5):867-8. [Medline].

  32. Sardy M, Csikos M, Geisen C, et al. Tissue transglutaminase ELISA positivity in autoimmune disease independent of gluten-sensitive disease. Clin Chim Acta. 2007 Feb. 376(1-2):126-35. [Medline].

  33. Smith JB, Taylor TB, Zone JJ. The site of blister formation in dermatitis herpetiformis is within the lamina lucida. J Am Acad Dermatol. 1992 Aug. 27(2 Pt 1):209-13. [Medline].

  34. Madan V, Jamieson LA, Bhogal BS, Wong CS. Inflammatory epidermolysis bullosa acquisita mimicking toxic epidermal necrolysis and dermatitis herpetiformis. Clin Exp Dermatol. 2009 Jul 29. [Medline].

  35. Van L, Browning JC, Krishnan RS, Kenner-Bell BM, Hsu S. Dermatitis herpetiformis: potential for confusion with linear IgA bullous dermatosis on direct immunofluorescence. Dermatol Online J. 2008 Jan 15. 14(1):21. [Medline]. [Full Text].

  36. Ko CJ, Colegio OR, Moss JE, McNiff JM. Fibrillar IgA deposition in dermatitis herpetiformis-an underreported pattern with potential clinical significance. Journal of cutaneous pathology. 2010. 37:475-477.

  37. Ciacci C, Ciclitira P, Hadjivassiliou M, Kaukinen K, Ludvigsson JF, McGough N, et al. The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis. United European Gastroenterol J. 2015 Apr. 3 (2):121-35. [Medline].

  38. Koskinen O, Villanen M, Korponay-Szabo I, et al. Oats do not induce systemic or mucosal autoantibosy response in children with coeliac disease. Pediartic Gastroentol Nutr. 2009. 48:559-65.

  39. Reunala T, Collin P, Holm K, et al. Tolerance to oats in Dermatitis Herpetiformis. Gut. 1998. 43:490-493.

  40. Thompson, T, Lee AR, Grace T. Gluten Contamination of Grains, Seeds and Flours in the United States: A pilot study. American Diabetic Association. 2010. 110:967-940.

  41. Thompson T, Dennis M, Higgins LA, Lee AR, Sharrett MK. Gluten free diet survey: are Americans with coeliac disease consuming recommended amounts of fiber, iron, calcium and grain foods. J Hum Nutr Diet. 2005. 18:163-9.

  42. Paek SY, Steinberg SM, Katz SI. Remission in dermatitis herpetiformis: a cohort study. Arch Dermatol. 2011 Mar. 147(3):301-5. [Medline].

  43. Sladden MJ, Johnston GA. Complete resolution of dermatitis herpetiformis with the Atkins' diet. Br J Dermatol. 2006 Mar. 154(3):565-6. [Medline].

  44. Smith JB, Fowler JB, Zone JJ. The effect of ibuprofen on serum dapsone levels and disease activity in dermatitis herpetiformis. Arch Dermatol. 1994 Feb. 130(2):257-9. [Medline].

  45. AGA Institute. AGA Institute Medical Position Statement on the Diagnosis and Management of Celiac Disease. Gastroenterology. 2006 Dec. 131 (6):1977-80. [Medline].

  46. Kadunce DP, McMurry MP, Avots-Avotins A, Chandler JP, Meyer LJ, Zone JJ. The effect of an elemental diet with and without gluten on disease activity in dermatitis herpetiformis. J Invest Dermatol. 1991 Aug. 97(2):175-82. [Medline].

  47. Zeedijk N, van der Meer JB, Poen H, van der Putte SC. Dermatitis herpetiformis: consequences of elemental diet. Acta Derm Venereol. 1986. 66(4):316-20. [Medline].

  48. Swerdlow AJ, Whittaker S, Carpenter LM, English JS. Mortality and cancer incidence in patients with dermatitis herpetiformis: a cohort study. Br J Dermatol. 1993 Aug. 129(2):140-4. [Medline].

  49. Lewis NR, Logan RF, Hubbard RB, West J. No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: a cohort study. Aliment Pharmacol Ther. 2008 Jun 1. 27(11):1140-7. [Medline].

  50. Viljamaa M, Kaukinen K, Pukkala E, Hervonen K, Reunala T, Collin P. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis. 2006 Jun. 38(6):374-80. [Medline].

  51. Hervonen K, Vomanen M, Kaitiainen H, Collin P, Reunala T. Lymphoma in patients with dermatitis herpetiformis and their first-degree relatives. Br J Dermatol. 2005 Jan. 152(2):82-6. [Medline].

Previous
Next
 
Light micrograph shows neutrophils in the dermal papillae, with fibrin deposition, neutrophil fragments, and edema (hematoxylin and eosin stain).
Papillary microabscesses form and progress to subepidermal vacuolization and vesicle formation in the lamina lucida, the weakest portion of the dermoepidermal junction (hematoxylin and eosin stain).
Classic vesicles of dermatitis herpetiformis.
Immunofluorescence showing immunoglobulin A at the dermoepidermal junction (direct immunofluorescence stain).
Polymorphic lesions on extensor surface of arm.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.